about
Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan.Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agentsDevelopments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaPomalidomide-bortezomib-dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMMBortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
P50
description
researcher
@en
wetenschapper
@nl
name
Kazutaka Sunami
@en
Kazutaka Sunami
@nl
type
label
Kazutaka Sunami
@en
Kazutaka Sunami
@nl
prefLabel
Kazutaka Sunami
@en
Kazutaka Sunami
@nl
P31
P496
0000-0002-8229-7439